Predictors of neonatal adiposity and associations by fetal sex in women with gestational diabetes mellitus and normal glucose-tolerant women.


Journal

Acta diabetologica
ISSN: 1432-5233
Titre abrégé: Acta Diabetol
Pays: Germany
ID NLM: 9200299

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 13 08 2020
accepted: 09 10 2020
pubmed: 21 11 2020
medline: 2 4 2021
entrez: 20 11 2020
Statut: ppublish

Résumé

To determine predictors of neonatal adiposity and differences in associations by fetal sex in women with gestational diabetes mellitus (GDM), normal-weight and overweight (BMI ≥ 25 kg/m Skinfold thickness was measured in 576 newborns, and cord blood leptin, c-peptide and lipids in 327 newborns in a multi-centric prospective cohort study. Compared to neonates of normal-weight NGT women (327), neonates of women with GDM (97) were more often large-for-gestational age (LGA) (16.5% vs 8.6%, p = 0.024) ,but the macrosomia rate (8.2% vs 5.8%, p = 0.388), sum of skinfolds (13.9 mm ± 2.9 vs 13.3 mm ± 2.6, p = 0.067), neonatal fat mass (1333.0 g ± 166.8 vs 1307.3 g ± 160.9, p = 0.356), and cord blood biomarkers were not significantly different. Compared to neonates of normal-weight NGT women, neonates of overweight NGT women (152) had higher rates of macrosomia (12.5% vs 5.8%, p = 0.012), LGA (17.1% vs 8.6%, p = 0.006), higher sum of skinfolds (14.3 mm ± 2.6 vs 13.2 mm ± 2.6, p < 0.001), neonatal fat mass (1386.0 g ± 168.6 vs 1307.3 g ± 160.9, p < 0.001), % neonatal fat mass > 90th percentile (15.2% vs 7.1%, p < 0.001), without significant differences in cord blood biomarkers. Maternal BMI, fasting glycemia, triglycerides, gestational weight gain, cord blood leptin ,and cord blood triglycerides were independent predictors for neonatal adiposity. Gestational weight gain was positively associated with adiposity in boys only. Compared to neonates of normal-weight NGT women, neonates of GDM women have higher LGA rates but similar adiposity, while neonates of overweight NGT women have increased adiposity. Limiting gestational weight gain might be especially important in the male fetus to reduce neonatal adiposity.

Identifiants

pubmed: 33216207
doi: 10.1007/s00592-020-01619-0
pii: 10.1007/s00592-020-01619-0
doi:

Substances chimiques

C-Peptide 0
Leptin 0
Lipids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

341-354

Références

Dabelea D, Crume T (2011) Maternal environment and the transgenerational cycle of obesity and diabetes. Diabetes 60(7):1849–1855. https://doi.org/10.2337/db11-0400
doi: 10.2337/db11-0400 pubmed: 21709280 pmcid: 3121421
Lowe WL Jr, Scholtens DM, Lowe LP et al (2018) Association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity. JAMA 320(10):1005–1016. https://doi.org/10.1001/jama.2018.11628
doi: 10.1001/jama.2018.11628 pubmed: 30208453 pmcid: 6143108
Gillman MW, Ludwig DS (2013) How early should obesity prevention start? N Engl J Med 369(23):2173–2175. https://doi.org/10.1056/NEJMp1310577
doi: 10.1056/NEJMp1310577 pubmed: 24224559
Sewell MF, Huston-Presley L, Super DM, Catalano P (2006) Increased neonatal fat mass, not lean body mass, is associated with maternal obesity. Am J Obstet Gynecol 195(4):1100–1103. https://doi.org/10.1016/j.ajog.2006.06.014
doi: 10.1016/j.ajog.2006.06.014 pubmed: 16875645 pmcid: 16875645
Longmore DK, Barr ELM, Lee IL et al (2019) Maternal body mass index, excess gestational weight gain, and diabetes are positively associated with neonatal adiposity in the Pregnancy and Neonatal Diabetes Outcomes in Remote Australia (PANDORA) study. Pediatr Obes 14(4):e12490. https://doi.org/10.1111/ijpo.12490
doi: 10.1111/ijpo.12490 pubmed: 30650263
Samsuddin S, Arumugam PA, Md Amin MS et al (2020) Maternal lipids are associated with newborn adiposity, independent of GDM status, obesity and insulin resistance: a prospective observational cohort study. BJOG Int J Obstet Gynaecol 127(4):490–499. https://doi.org/10.1111/1471-0528.16031
doi: 10.1111/1471-0528.16031
Lee IL, Barr ELM, Longmore D et al (2020) Cord blood metabolic markers are strong mediators of the effect of maternal adiposity on fetal growth in pregnancies across the glucose tolerance spectrum: the PANDORA study. Diabetologia 63(3):497–507. https://doi.org/10.1007/s00125-019-05079-2
doi: 10.1007/s00125-019-05079-2 pubmed: 31915893
Kadakia R, Talbot O, Kuang A et al (2019) Cord blood metabolomics: association with newborn anthropometrics and c-peptide across ancestries. J Clin Endocrinol Metab 104(10):4459–4472. https://doi.org/10.1210/jc.2019-00238
doi: 10.1210/jc.2019-00238 pubmed: 31498869 pmcid: 6735762
Lima RA, Desoye G, Simmons D et al (2020) Temporal relationships between maternal metabolic parameters with neonatal adiposity in women with obesity differ by neonatal sex: secondary analysis of the DALI study. Pediatr Obes 15:e12628. https://doi.org/10.1111/ijpo.12628
doi: 10.1111/ijpo.12628 pubmed: 32141687 pmcid: 7317347
Crowther CA, Hiller JE, Moss JR et al (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352(24):2477–2486. https://doi.org/10.1056/NEJMoa042973
doi: 10.1056/NEJMoa042973 pubmed: 15951574
Landon MB, Spong CY, Thom E et al (2009) A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 361(14):1339–1348. https://doi.org/10.1056/NEJMoa0902430
doi: 10.1056/NEJMoa0902430 pubmed: 19797280 pmcid: 2804874
Catalano PM, Thomas A, Huston-Presley L, Amini SB (2003) Increased fetal adiposity: a very sensitive marker of abnormal in utero development. Am J Obstet Gynecol 189(6):1698–1704. https://doi.org/10.1016/s0002-9378(03)00828-7
doi: 10.1016/s0002-9378(03)00828-7 pubmed: 14710101
Logan KM, Gale C, Hyde MJ, Santhakumaran S, Modi N (2017) Diabetes in pregnancy and infant adiposity: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 102(1):F65–F72. https://doi.org/10.1136/archdischild-2015-309750
doi: 10.1136/archdischild-2015-309750 pubmed: 27231266
Benhalima K, Van Crombrugge P, Verhaeghe J et al (2014) The Belgian Diabetes in Pregnancy Study (BEDIP-N), a multi-centric prospective cohort study on screening for diabetes in pregnancy and gestational diabetes: methodology and design. BMC Pregnancy Childbirth 14:226. https://doi.org/10.1186/1471-2393-14-226
doi: 10.1186/1471-2393-14-226 pubmed: 25015413 pmcid: 4227277
Benhalima K, Van Crombrugge P, Moyson C et al (2018) The sensitivity and specificity of the glucose challenge test in a universal two-step screening strategy for gestational diabetes mellitus using the 2013 World Health Organization Criteria. Diabetes Care 41:e111–e112. https://doi.org/10.2337/dc18-0556
doi: 10.2337/dc18-0556 pubmed: 29748432
Benhalima K, Van Crombrugge P, Moyson C et al (2018) A modified two-step screening strategy for gestational diabetes mellitus based on the 2013 WHO criteria by combining the glucose challenge test and clinical risk factors. J Clin Med 7(10):351. https://doi.org/10.3390/jcm7100351
doi: 10.3390/jcm7100351 pmcid: 6210855
Benhalima K, Van Crombrugge P, Moyson C et al (2019) Characteristics and pregnancy outcomes across gestational diabetes mellitus subtypes based on insulin resistance. Diabetologia 62(11):2118–2128. https://doi.org/10.1007/s00125-019-4961-7
doi: 10.1007/s00125-019-4961-7 pubmed: 31338546
American Diabetes A (2013) Standards of medical care in diabetes—2013. Diabetes Care 36(Suppl 1):S11–66. https://doi.org/10.2337/dc13-S011
doi: 10.2337/dc13-S011
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419
doi: 10.1007/BF00280883
Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22(9):1462–1470
doi: 10.2337/diacare.22.9.1462
Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 46(1):3–19. https://doi.org/10.1007/s00125-002-1009-0
doi: 10.1007/s00125-002-1009-0 pubmed: 12637977
Kirwan JP, Huston-Presley L, Kalhan SC, Catalano PM (2001) Clinically useful estimates of insulin sensitivity during pregnancy: validation studies in women with normal glucose tolerance and gestational diabetes mellitus. Diabetes Care 24(9):1602–1607
doi: 10.2337/diacare.24.9.1602
Retnakaran R, Qi Y, Goran MI, Hamilton JK (2009) Evaluation of proposed oral disposition index measures in relation to the actual disposition index. Diabet Med J Br Diabet Assoc 26(12):1198–1203. https://doi.org/10.1111/j.1464-5491.2009.02841.x
doi: 10.1111/j.1464-5491.2009.02841.x
Guidelines of Institute of Medicine (2009) Weight gain during pregnancy: reexamining the guidelines. In: Rasmussen KM YA (ed). In National Academies Press (US). The National Academies Collection: Reports funded by National Institutes of Health
HAPO study Group (2009) Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 58(2):453–459. https://doi.org/10.2337/db08-1112
doi: 10.2337/db08-1112
Catalano PM, Thomas AJ, Avallone DA, Amini SB (1995) Anthropometric estimation of neonatal body composition. Am J Obstet Gynecol 173(4):1176–1181. https://doi.org/10.1016/0002-9378(95)91348-3
doi: 10.1016/0002-9378(95)91348-3 pubmed: 7485315 pmcid: 7485315
Devlieger HMG, Bekaert A, Eeckels R (2000) Standaarden van geboortegewicht-voor-zwangerschapsduur voor de Vlaamse boreling. Tijdschr voor Geneeskunde 56(1):1–14
doi: 10.2143/TVG.56.1.5000625
Larque E, Labayen I, Flodmark CE et al (2019) From conception to infancy—early risk factors for childhood obesity. Nat Rev Endocrinol 15(8):456–478. https://doi.org/10.1038/s41574-019-0219-1
doi: 10.1038/s41574-019-0219-1 pubmed: 31270440
Herrera E, Ortega-Senovilla H (2018) Implications of lipids in neonatal body weight and fat mass in gestational diabetic mothers and non-diabetic controls. Curr Diabetes Rep 18(2):7. https://doi.org/10.1007/s11892-018-0978-4
doi: 10.1007/s11892-018-0978-4
Poston L, Bell R, Croker H et al (2015) Effect of a behavioural intervention in obese pregnant women (the UPBEAT study): a multicentre, randomised controlled trial. Lancet Diabetes Endocrinol 3(10):767–777. https://doi.org/10.1016/S2213-8587(15)00227-2
doi: 10.1016/S2213-8587(15)00227-2 pubmed: 26165396
Simmons D, Devlieger R, van Assche A et al (2017) Effect of physical activity and/or healthy eating on GDM risk: the DALI lifestyle study. J Clin Endocrinol Metab 102(3):903–913. https://doi.org/10.1210/jc.2016-3455
doi: 10.1210/jc.2016-3455 pubmed: 27935767
Koivusalo SB, Rono K, Klemetti MM, Roine RP et al (2016) Gestational diabetes mellitus can be prevented by lifestyle intervention: the Finnish Gestational Diabetes Prevention Study (RADIEL): a randomized controlled trial. Diabetes Care 39(1):24–30. https://doi.org/10.2337/dc15-0511
doi: 10.2337/dc15-0511 pubmed: 26223239
Dodd JM, Turnbull D, McPhee AJ et al (2014) Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial. BMJ 348:g1285. https://doi.org/10.1136/bmj.g1285
doi: 10.1136/bmj.g1285 pubmed: 24513442 pmcid: 3919179
Eder M, Csapo B, Wadsack C et al (2016) Sex differences in the association of cord blood insulin with subcutaneous adipose tissue in neonates. Int J Obes 40(3):538–542. https://doi.org/10.1038/ijo.2015.185
doi: 10.1038/ijo.2015.185
van Poppel MN, Eder M, Lang U, Desoye G (2018) Sex-specific associations of insulin-like peptides in cord blood with size at birth. Clin Endocrinol 89(2):187–193. https://doi.org/10.1111/cen.13739
doi: 10.1111/cen.13739
Castro NP, Euclydes VV, Simoes FA et al (2017) The relationship between maternal plasma leptin and adiponectin concentrations and newborn adiposity. Nutrients 9(3):182. https://doi.org/10.3390/nu9030182
doi: 10.3390/nu9030182 pmcid: 5372845
Loy SL, Wee PH, Colega MT et al (2017) Maternal night-fasting interval during pregnancy is directly associated with neonatal head circumference and adiposity in girls but not boys. J Nutr 147(7):1384–1391. https://doi.org/10.3945/jn.117.250639
doi: 10.3945/jn.117.250639 pubmed: 28592516 pmcid: 5483968
Chen LW, Tint MT, Fortier MV et al (2018) Which anthropometric measures best reflect neonatal adiposity? Int J Obes 42(3):501–506. https://doi.org/10.1038/ijo.2017.250
doi: 10.1038/ijo.2017.250

Auteurs

Katrien Benhalima (K)

Department of Endocrinology, University Hospital Gasthuisberg, KU Leuven, Herestraat 49, 3000, Leuven, Belgium. katrien.benhalima@uzleuven.be.

Anaïs De Landtsheer (A)

Department of Endocrinology, University Hospital Gasthuisberg, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.

Paul Van Crombrugge (P)

Department of Endocrinology, OLV Ziekenhuis Aalst-Asse-Ninove, Moorselbaan 164, 9300, Aalst, Belgium.

Carolien Moyson (C)

Department of Endocrinology, University Hospital Gasthuisberg, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.

Johan Verhaeghe (J)

Department of Obstetrics and Gynecology, University Hospital Gasthuisberg, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.

Hilde Verlaenen (H)

Department of Obstetrics and Gynecology, OLV Ziekenhuis Aalst-Asse-Ninove, Moorselbaan 164, 9300, Aalst, Belgium.

Chris Vercammen (C)

Department of Endocrinology, Imelda ziekenhuis, Imeldalaan 9, 2820, Bonheiden, Belgium.

Toon Maes (T)

Department of Endocrinology, Imelda ziekenhuis, Imeldalaan 9, 2820, Bonheiden, Belgium.

Els Dufraimont (E)

Department of Obstetrics and Gynecology, Imelda ziekenhuis, Imeldalaan 9, 2820, Bonheiden, Belgium.

Christophe De Block (C)

Department of Endocrinology-Diabetology-Metabolism, Antwerp University Hospital, Wilrijkstraat 10, 2560, Edegem, Belgium.

Yves Jacquemyn (Y)

Department of Obstetrics and Gynecology, Antwerp University Hospital and Global Health Institute GHI Antwerp University, Wilrijkstraat 10, 2650, Edegem, Belgium.

Annouschka Laenen (A)

Center of Biostatics and Statistical Bioinformatics, KU Leuven, Kapucijnenvoer 35 Bloc d - Box 7001, 3000, Leuven, Belgium.

Roland Devlieger (R)

Department of Obstetrics and Gynecology, University Hospital Gasthuisberg, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.

Caro Minschart (C)

Department of Endocrinology, University Hospital Gasthuisberg, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.

Chantal Mathieu (C)

Department of Endocrinology, University Hospital Gasthuisberg, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH